Teitl: Multi-centre randomized double-blind parallel-group active-controlled superiority study to compare the efficacy and safety of poesimod to teriflunomide to teriflunomid in subjects with relapsing multiple sclerosis

Arianwyr
Cardiff & Vale University Health Board

Prif Ymchwiliwr

Manylion y Prosiect
Gwerth net y ffigur a ddyfarnwyd i Brifysgol Caerdydd: £26,089.00
Dyddiad dechrau: 27.07.2016
Dyddiad gorffen: 31.12.2016

Diweddarwyd y tro diwethaf ar 2020-30-11 am 06:02